Get started
Author

Heather M. Duncan

Observed names: Duncan, Heather M, Heather Duncan, Heather M Duncan
ORCID: 0000-0001-6176-4846
Observed ORCID: 0000-0001-6176-4846
OpenAlex ID: A5012779265
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
2018 · Clotilde Théry, Kenneth W Witwer, et al. · Journal of Extracellular Vesicles · 11,061
PDF
Survival transplantation of preserved non–heart-beating donor rat livers: preservation by hypothermic machine perfusion1
2003 · Charles Y. Lee, Shailendra Jain, et al. · Transplantation · 80
Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2019 · Zeinab Sharifi, Bassam Abdulkarim, et al. · Clinical Cancer Research · 51
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
2019 · Meaghan Boileau, Margret Shirinian, et al. · Nature Communications · 48
PDF
Identification of Existing Bioactive Compounds That Target Acute Myeloid Leukemia Stem Cells
2015 · Isabelle Laverdiere, Andrea L. Neumann, et al. · Blood · 2
Recovery of Energy Stores of Non-Heart-Beating Donor Livers Following Preservation by Hypothermic Machine Perfusion
2003 · Charles Y. Lee, Heather M. Duncan, et al. · 2
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
2018 · Théry, Clotilde, Witwer, Kenneth W, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 1
G protein-coupled receptor 56 as a potential regulator of normal and leukemic stem cells
2016 · Heather Duncan, Karin Hermans, et al. · Experimental Hematology · 1
Effects of Bisphenol A and Diethylstilbestrol on Estrogen Receptor Expression and Male Fertility
2011 · Heather M Duncan, Karen P Phillips · Revue interdisciplinaire des sciences de la santé - Interdisciplinary Journal of Health Sciences · 1
PDF
Supplementary Legend from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure 7 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Table S2 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Table S3 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure 6 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Table S1 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure S2 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure S4 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure S1 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure 5 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Table S4 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure S3 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Table S3 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure S1 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Legend from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Supplementary Figure 7 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
2023 · Zeinab Sharifi, Bassam Abdulkarim, et al.
Works count: 37
Citation count: 11,220
H-index: 4
I10-index: 4
Year
Topic
Type